Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Enrolling by Invitation

ASH Research Collaborative Data Hub

NCT05775224

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +20 more
Locations: ASH Research Collaborative Washington D.C., District of Columbia, United States

View Trial Details

Enrolling by Invitation

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

NCT06245031

Conditions: AD, Alzheimer Disease, Brain Diseases, +25 more
Locations: Barrow Neurological Institute Phoenix, Arizona, United States

CCT Research - Foothills Research Center Phoenix, Arizona, United States

Banner Sun Health Research Institute Sun City, Arizona, United States

Advanced Research Center, Inc Anaheim, California, United States

View all 53 locations

View Trial Details

Enrolling by Invitation

Autologous Stem Cell Transplantation for Patients With AL Amyloidosis

NCT04210791

Conditions: AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +14 more
Locations: National Clinical Research Center of Kidney Diseases, Jinling Hospital Nanjing, Jiangsu, China

View Trial Details

Enrolling by Invitation

Chidamide in Patients With Recurrent and Refractory Diffuse Large b

NCT05690191

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Second Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Enrolling by Invitation

Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL

NCT04491721

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing, China

View Trial Details

Enrolling by Invitation

A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM)

NCT03815279

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Landspitali University Hospital Reykjavik, Iceland

View Trial Details

Not Yet Recruiting

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

NCT07524530

Conditions: Core Binding Factor Alpha Subunits, Hematologic Diseases, Hematologic Neoplasms, +10 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Not Yet Recruiting

Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)

NCT07572136

Conditions: Acute Lymphoblastic Leukemia, B-ALL, Hematologic Diseases, +10 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Not Yet Recruiting

A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.

NCT06970496

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, China

Zhujiang Hospital of Southern Medical University Guangzhou, China

Jiangxi Cancer Hospital Nanchang, China

Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China

View Trial Details

Not Yet Recruiting

Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study

NCT07662928

Conditions: Adult Burkitt Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions